Chemical Structure (Gabapenin 01)
Not available.*
Gabapentin Capsule
Product Images NDC 82804-217
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 82804-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Gabapenin 02)
Figure 2 (Gabapenin 03)
This text provides data on the Mean Pain Score for different treatment groups, including a placebo group and two Gabapentin dosage groups (1,800 mg/day and 2,400 mg/day). The study appears to span over a fixed dose period, with baseline measurements at the start.*
Figure 3 (Gabapenin 04)
This text provides a series of percentages ranging from 0% to 100%. It also includes references to "study 1" and "study 2." The data may represent progress, evaluation results, or comparisons between different studies or scenarios.*
Figure 4 (Gabapenin 05)
82804-217-30 (Image 01)
This is a description of Gabapentin 300mg capsules from Proficient Rx. The capsules are white with grey "300 mg" imprint on the body and grey "OE B57" on the cap. The medication is white or off-white powder and should be stored at 25°C. Each package contains 30 capsules and comes with a Medication Guide. The product is manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. in China. Remember to keep the medication out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
